Unlock stock picks and a broker-level newsfeed that powers Wall Street.

KSE - Delayed Quote KRW

Cosmo Chemical Co., Ltd. (005420.KS)

15,160.00
-340.00
(-2.19%)
At close: 3:30:26 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
749,281,395.08
749,281,395.08
798,983,652.89
718,194,570.10
512,614,348.13
Cost of Revenue
707,988,158.39
707,988,158.39
752,408,941.08
637,449,553.46
448,345,639.57
Gross Profit
41,293,236.69
41,293,236.69
46,574,711.81
80,745,016.64
64,268,708.56
Operating Expense
43,294,136.86
43,294,136.86
43,569,117.66
39,317,093.21
33,784,889.88
Operating Income
-2,000,900.17
-2,000,900.17
3,005,594.15
41,427,923.43
30,483,818.68
Net Non Operating Interest Income Expense
-10,179,799.51
-10,179,799.51
-7,490,009.16
-6,669,002.41
-6,032,342.22
Pretax Income
-45,663,281.43
-45,663,281.43
-6,871,600.70
36,014,119.11
28,498,606.59
Tax Provision
6,620,842.21
6,620,842.21
598,318.13
4,542,448.17
4,995,445.57
Net Income Common Stockholders
-64,679,943.88
-64,679,943.88
-26,827,308.71
11,243,598.97
10,886,891.26
Basic EPS
-1.69k
--
-754.00
327.60
296.02
Diluted EPS
-1.69k
--
-754.00
327.60
296.02
Basic Average Shares
38,362.96
--
35,579.99
34,320.78
36,777.57
Diluted Average Shares
38,362.96
--
35,579.99
34,320.78
36,777.57
Total Operating Income as Reported
-2,000,900.28
-2,000,900.28
3,005,594
41,427,923.29
30,483,818.55
Rent Expense Supplemental
612,720.76
612,720.76
763,727.97
339,990.06
85,758.11
Total Expenses
751,282,295.25
751,282,295.25
795,978,058.74
676,766,646.67
482,130,529.45
Net Income from Continuing & Discontinued Operation
-64,679,943.88
-64,679,943.88
-26,827,308.71
11,243,598.97
10,886,891.26
Normalized Income
-41,747,737.90
-41,747,737.90
-27,948,335.90
10,792,769.44
5,064,885.14
Interest Income
553,277.89
553,277.89
1,412,714.21
654,877.71
765,670.24
Interest Expense
10,709,225.36
10,709,225.36
9,411,677.11
7,303,891.65
6,531,132
Net Interest Income
-10,179,799.51
-10,179,799.51
-7,490,009.16
-6,669,002.41
-6,032,342.22
EBIT
-34,954,056.07
-34,954,056.07
2,540,076.41
43,318,010.76
35,029,738.59
EBITDA
-4,338,718.82
-4,338,718.82
27,028,187.30
69,332,859.57
59,020,809.88
Reconciled Cost of Revenue
707,988,158.39
707,988,158.39
752,408,941.08
637,449,553.46
448,345,639.57
Reconciled Depreciation
30,615,337.25
30,615,337.25
24,488,110.89
26,014,848.81
23,991,071.29
Net Income from Continuing Operation Net Minority Interest
-64,679,943.88
-64,679,943.88
-26,827,308.71
11,243,598.97
10,886,891.26
Total Unusual Items Excluding Goodwill
-30,173,955.24
-30,173,955.24
1,475,035.78
515,899.79
7,059,436.04
Total Unusual Items
-30,173,955.24
-30,173,955.24
1,475,035.78
515,899.79
7,059,436.04
Normalized EBITDA
25,835,236.42
25,835,236.42
25,553,151.52
68,816,959.78
51,961,373.84
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-7,241,749.26
-7,241,749.26
354,008.59
65,070.26
1,237,429.92
12/31/2021 - 1/4/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade